World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
36613
World Ranking
1062
National Ranking
573

Medicine

D-Index
90
Citations
36716
World Ranking
12063
National Ranking
6190

Simon Mallal publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Simon Mallal sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 700 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Simon Mallal D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Simon Mallal sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Simon Mallal is affiliated with Vanderbilt University Medical Center in the United States. Their research spans multiple fields, with a primary focus on medicine and immunology and microbiology. Within these broader categories, they have concentrated on subfields including immunology, infectious diseases, molecular biology, epidemiology, and emergency medicine.

The scientist's research topics cover a range of subjects related to immune function, infectious agents, and treatment. Notable areas include immune cell function and interaction, HIV-related health complications and treatments, SARS-CoV-2 and COVID-19 research, HIV research and treatment, vaccines and immunoinformatics approaches, drug-induced adverse reactions, and immunotherapy and immune responses.

Simon Mallal has coauthored numerous publications with several frequent collaborators, such as Elizabeth J. Phillips, Celestine N. Wanjalla, Alessandro Sette, Abha Chopra, and Spyros A. Kalams.

The venues where Mallal has published most frequently include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • Nature
  • The Laryngoscope
  • JAMA Network Open

Among recent papers authored or coauthored by Simon Mallal are the following:

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans (2020, Science)
  • Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis (2020, Science Advances)
  • SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron (2022, Cell)
  • Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases (2021, Cell Reports Medicine)
  • α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease (2020, Nature Communications)

The scientist has received recognition through several awards, including being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2014 and membership in the Association of American Physicians.

Best Publications

  • HLA-B*5701 Screening for Hypersensitivity to Abacavir

    Simon Mallal;Elizabeth Phillips;Giampiero Carosi;Jean-Michel Molina

  • Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

    S. Mallal;S. Mallal;D. Nolan;C. Witt;C. Witt;G. Masel;G. Masel

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

    Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney

  • Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

    Photini Kiepiela;Alasdair J. Leslie;Isobella Honeyborne;Danni Ramduth

  • Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level

    Corey B. Moore;Mina John;Ian R. James;Frank T. Christiansen;Frank T. Christiansen

  • SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

    Unknown

  • T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote

  • RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors

    Sherene Loi;Sherene Loi;Sathana Dushyanthen;Paul A. Beavis;Roberto Salgado

  • Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.

    Simon A Mallal;Mina John;Corey B. Moore;Ian R. James

  • The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

    Patricia Price;C. Witt;R. Allcock;D. Sayer

  • Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.

    Alison Tarke;Alison Tarke;John Sidney;Conner K. Kidd;Jennifer M. Dan;Jennifer M. Dan

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

    Annalise M. Martin;David Nolan;Silvana Gaudieri;Silvana Gaudieri;Coral Ann Almeida

  • Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

    M.A. French;N. Lenzo;M. John;S.A. Mallal

  • Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

    David A. Ostrov;Barry J. Grant;Yuri A. Pompeu;John Sidney

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • High Sensitivity of Human Leukocyte Antigen-B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

    Michael Saag;Rukmini Balu;Elizabeth Phillips;Philip Brachman

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

    J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

David Nolan
David Nolan Royal Perth Hospital
Mina John
Mina John Royal Perth Hospital
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
Silvana Gaudieri
Silvana Gaudieri University of Western Australia
Ian James
Ian James Perron Institute for Neurological and Translational Science
Andri Rauch
Andri Rauch University of Bern
Jonathan M. Carlson
Jonathan M. Carlson Microsoft (United States)
Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University
Bruce D. Walker
Bruce D. Walker Harvard University
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students consider nursing pathways that complement immunological research and patient care.

Accelerated programs help students enter the workforce quickly. For example, accelerated np programs online offer a fast track to becoming a Nurse Practitioner with flexible study options. This is ideal for those wanting advanced clinical roles.

Non-nurses seeking entry into nursing might find online RN programs for non nurses in Florida a valuable resource. These programs allow students to transition into nursing without prior experience, often fully online.

Additionally, shorter duration programs like 12-month accelerated nursing programs enable students to earn a BSN quickly and enter immunology-related healthcare roles faster.

For those starting at the foundational level, understanding which LPN programs are easiest to get into can help find accessible pathways into nursing, supporting a career connected to immunological health.

Best Scientists Citing Simon Mallal

Trending Scientists

Recently Published Articles